Evrys Bio is a pharmaceutical company for providing health care solutions to defend against the virus.
Evrys Bio has raised $34.3M in total funding. The most recent round was Grant. The last funding was announced in July 2021.
Evrys Bio's investors include Keiretsu Capital, Mid Atlantic Bio Angels, Defense Threat Reduction Agency (DTRA), ShangPharma Innovation.
Evrys Bio is headquartered in Doylestown, United States.
Evrys Bio is a pharmaceutical company for providing health care solutions to defend against the virus.
Evrys Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Evrys Bio — Funding & Investors." VCBacked, July 13, 2021, https://www.vcbacked.co/company/evrys-bio. Accessed August 14, 2026.
VCBacked. (2021). Evrys Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/evrys-bio
{{cite web |title=Evrys Bio — Funding & Investors |url=https://www.vcbacked.co/company/evrys-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated